A small-scale randomised controlled trial of home telemonitoring in patients with severe chronic obstructive pulmonary disease. (August 2017)

• Record Type: Journal Article
• Authors: Shany, Tal; Hession, Michael; Pryce, David; Roberts, Mary; Basilakis, Jim; Redmond, Stephen; Lovell, Nigel; Schreier, Guenter
• Is Part Of: Journal of telemedicine and telecare. Volume 23:Number 7(2017)
• Page Start: 650
• Page End: 656
• Publication Date: 2017-08
• Subjects: Home telecare -- telemedicine -- cost-effectiveness -- remote consultation; Telecommunication in medicine -- Periodicals; 610
• DOI: 10.1177/1357633X16659410
• Languages: English
• ISSNs: 1357-633X

Abstract

Introduction: This was a pilot study to examine the effects of home telemonitoring (TM) of patients with severe chronic obstructive pulmonary disease (COPD). Methods: A randomised controlled 12-month trial of 42 patients with severe COPD was conducted. Home TM of oximetry, temperature, pulse, electrocardiogram, blood pressure, spirometry, and weight with telephone support and home visits was tested against a control group receiving only identical telephone support and home visits. Results: The results suggest that TM had a reduction in COPD-related admissions, emergency department presentations, and hospital bed days. TM also seemed to increase the interval between COPD-related exacerbations requiring a hospital visit and prolonged the time to the first admission. The interval between hospital visits was significantly different between the study arms, while the other findings did not reach significance and only suggest a trend. There was a reduction in hospital admission costs. TM was adopted well by most patients and eventually, also by the nursing staff, though it did not seem to change patients' psychological well-being. Discussion: Ability to draw firm conclusions is limited due to the small sample size. However the trends of reducing hospital visits warrant a larger study of a similar design. When designing such a trial, one should consider the potential impact of the high quality of care already made available to this patient cohort.